Understanding Ovarian Cancer, Recurrence, Clinical Trials & Equity of Care

Поделиться
HTML-код
  • Опубликовано: 22 фев 2023
  • In this episode of CONNECT OVAR COFFEE ☕️, Dr. B J Rimel, Medical Director, Clinical Trials Office, at Cedars Sinai Medical Center, joins us to Talk About Understanding Ovarian Cancer, Recurrence, Clinical Trials & MORE! Let's Learn. Let's #ConnectOvarCoffee! ☕️

Комментарии • 4

  • @Ovarcome
    @Ovarcome  Год назад

    Thank you for the candid guidance and advice on clinical trials Dr. Rimel!

  • @Ovarcome
    @Ovarcome  Год назад

    Hello Ovarcomers, and welcome to this episode of CONNECT OVAR COFFEE ☕ ! We are so happy to have you join us today. If you have any questions, please add in the comments section - thank you!

  • @sharluck_ana
    @sharluck_ana Год назад

    done my surgery and chemo treatment last year , still afraid in recurrence :(

  • @Ovarcome
    @Ovarcome  Год назад

    I see most clinical trials require measurable disease. What percentage of ovarian cancer patients never get measurable disease per RECIST criteria?